THE TRANSITION TOWARS PERSONALIZED MEDICINE
2008
2011
TIME LINE
The most patients with KRAS codon 12-13 WT do NOT responded to antiEGFR
1022 tumour samples
of european patients
with
antiEGFR-QT
773 quality DNA
analysis for MUT
END-POINT
OR WT vs MUT
De Roock W. Lancet Oncol. 2010
25
